Welcome to the e-CCO Library Archive!
M. Guirgis1, E. Wendt1, L.M. Wang2, P. Basset3, D. Burger1, A. Kent1, R. Adamson1, S. Travis1, S. Keshav1, 1Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, United Kingdom, 2Department of Cellular Pathology, John Radcliffe Hospital, Oxford, United Kingdom, 3StatsConsultancy Limited, United Kingdom
Calprotectin predicts relapse of IBD even in the presence of a 'normal' colonoscopy
R. Deberry, A. Rahman, P. Dubois, G. Chung-Faye, B. Hayee*
King's College Hospital NHS Foundation Trust, Gastroenterology, London, United Kingdom
IBD-Unclassified in childhood and adolescence; a complicated diagnosis
D.A. Winter1, J.C. Escher1, E. Porto2, IBD Working Group of ESPGHAN, 1Erasmus MC-Sophia Children's Hospital, Pediatric Gastroenterology, Rotterdam, Netherlands, 2European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Porto, Portugal
D. Trabulo1, C. Martins1, S. Ribeiro1, C. Cardoso1, J. Mangualde1, I. Cremers1, A.P. Oliveira1, 1Centro Hospitalar de Setúbal – Hospital de São Bernardo, Gastroenterology, Setúbal, Portugal
Gender-related differences in work productivity impairment and quality of life in Inflammatory Bowel Disease (IBD): A cross-sectional survey from Southern Italy
M. Cappello*, R. Alloro, M. Mazza, M. Mendolaro, P.L. Almasio, A. Craxì
University of Palermo, Gastroenterology Section, DiBiMis, Palermo, Italy
How to ameliorate histology accuracy in IBD diagnosis: role for a better interaction between clinicians and pathologists?
M. Daperno1,2, G. Canavese3, R. Suriani1, A. Sapino3, R. Rocca1,2, V. Villanacci4, O. Onlus1, on behalf of Fondazione IBD, 1Fondazione IBD Onlus, IBD Foundation, Torino, Italy, 2AO Ordine Mauriziano, Gastroenterology Division, Turin, Italy, 3AO S. Giovanni Battista – Città della Salute, Pathology Department, Torino, Italy, 4Spedali Civili di Brescia, Pathology Depratment, Brescia, Italy
A.-M.K. Fiehn1, C. Bjørnbak2, M. Warnecke3, P.J.H. Engel1, L.K. Munck2, 1Roskilde Sygehus, Dept. of Pathology, Roskilde, Denmark, 2Køge sygehus, Dept. of Int. Med., Køge, Denmark, 3Slagelse Sygehus, Dept. of Pathology, Slagelse, Denmark
Serum biomarkers predict disease severity in Ulcerative Colitis
C. Soendergaard*1, O.H. Nielsen1, J.B. Seidelin1, P.H. Kvist2, J.T. Bjerrum1
1Herlev University Hospital, Department of Gastroenterology, Copenhagen, Denmark, 2Novo Nordisk A/S, Histology, Maaloev, Denmark
High prevalence of subclinical ultrasonographic synovitis in patients with inflammatory bowel disease
E. Vicente1, S. Pérez2, M. Chaparro3, F. Rodríguez-Salvanés4, S. Castañeda1, J.P. Gisbert3, 1Hospital La Princesa, IIS-P, Rheumatology Department, Madrid, Spain, 2Fundación Jiménez Díaz, Rheumatology Department, Madrid, Spain, 3Hospital Universitario de La Princesa, IP and CIBERehd, Gastroenterology Unit, Madrid, Spain, 4Hospital La Princesa, IIS-P, Epidemiologic Research Unit, Madrid, Spain
S.P. Travis1, D. Schnell2, P. Krzeski3, J.-F. Colombel4, B.G. Feagan5, W. Reinisch6, B.E. Sands7, B.R. Yacyshyn8, C.A. Bernhardt9, J.-Y. Mary10, W.J. Sandborn11, 1Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, United Kingdom, 2Middletown, United States, 3Warner Chilcott, Weybridge, United Kingdom, 4Hôpital Claude Huriez, Centre Hospitalier Universitaire de Lille, Lille, France, 5University of Western Ontario, Robarts Clinical Trials, Robarts Research Institute, Ontario, Canada, 6Universitatsklinik Innere Medizin III, Abteilung Gastroenterologie und Hepatologie, Medical University of Vienna, Vienna, Austria, 7Mount Sinai Hospital, New York, United States, 8University of Cincinnati, Division of Digestive Diseases, Cincinnati, Ohio, United States, 9Bernhardt Regulatory Consulting, Cincinnati, Ohio, United States, 10INSERM U717 Biostatistics and Clinical Epidemiology, Universite Paris Diderot, Paris, France, 11Division of Gastroenterology, University of California San Diego, La Jolla, California, United States
A systematic review and meta-analysis of non-invasive biomarkers for assessing disease activity in Inflammatory Bowel Disease
M.H. Mosli*1, 2, G. Zou1, 3, S.K. Garg4, S.G. Feagan1, J.K. MacDonald1, W.J. Sandborn1, 5, N. Chande6, B.G. Feagan1, 3, 7
1Robarts Clinical Trials Inc., Robarts Research Institute, University of Western Ontario, London, Ontario, Canada, 2King Abdulaziz University, Department of Medicine, Jeddah, Saudi Arabia, 3University of Western Ontario, Department of Epidemiology and Biostatistics, London Ontario, Canada, 4University of Minnesota, Department of Medicine, Minneapolis, United States, 5University of California San Diego, Division of Gastroenterology, La Jolla, United States, 6London Health Sciences Centre, Victoria Hospital, London, Canada, 7University of Western Ontario, Department of Medicine, London , Canada
Health-related quality of life among patients with primary sclerosing cholangitis
J. Haapamäki1, H. Sintonen2, N. Barner-Rasmussen1, M. Färkkilä1, 1Helsinki University Central Hospital, Division of Gastroenterology, Helsinki, Finland, 2University of Helsinki, Department of Public Health, Hjelt Institute, Helsinki, Finland
L. Guidi1, M. Marzo1, G. Andrisani1, C. Felice1, D. Pugliese1, I. De Vitis1, A. Papa1, G.L. Rapaccini1, F. Forni2, A. Armuzzi1, 1Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy, 2Clinical Laboratory Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy